Journal
NEUROCHEMICAL RESEARCH
Volume 46, Issue 11, Pages 3003-3011Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-021-03408-9
Keywords
ALKBH5; G6PD; Glioma; m6A modification
Categories
Funding
- Scientific Research Fund Project of Hebei Provincial Health Commission [20211353]
Ask authors/readers for more resources
This study revealed that the upregulation of ALKBH5 in glioma promotes cell proliferation by demethylating G6PD and enhancing PPP activity. ALKBH5 could serve as a potential therapeutic target for glioma.
This study aims to investigate the biological role of 6-methyladenine (m6A) methylation in inducing the carcinogenesis of glioma and its proliferation. Relative levels of ALKBH5 and glucose-6-phosphate dehydrogenase (G6PD) in glioma tissues and cell lines were determined by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. Gain-of-function and loss-of-function approaches were used to investigate the role of ALKBH5 in mediating proliferation and energy metabolism of glioma cells. The regulatory effect of ALKBH5 on G6PD was analyzed using m6A-qRT-PCR. Our results showed that ALKBH5 was upregulated in glioma, which stimulated glioma cells to proliferate. Serving as a m6A eraser, ALKBH5 demethylated the target transcript G6PD and enhanced its mRNA stability, thereby promoting G6PD translation and activating the pentose phosphate pathway (PPP). Collectively, ALKBH5 stimulates glioma cells to proliferate through erasing the m6A methylation of G6PD, which can be utilized as a potential therapeutic target for glioma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available